🎥 Missed our webinar, Understanding the Value of Your Repurposed Medicine? You can now watch the full recording through the REMEDi4ALL Digital Academy. 🎓 Watch the webinar and start learning for free today: https://loom.ly/IeBJ9No

⏰ Final reminder! Join our webinar on Understanding the Value of Your Repurposed Medicine. Hear from Prof. Zoltán Kaló, Diana Kwast-Hoekstra and Dalma Hosszú on HTA, patient evidence and how early planning can strengthen drug repurposing. 👉 Register: https://loom.ly/P2DRFRA

Congratulations to Prof. Zoltán Kaló, co-founder of REMEDi4ALL partner Syreon Research Institute, on his appointment as Director General of Hungary’s National Health Insurance Fund. We look forward to continuing our collaboration through the REMEDi4ALL Policy Board. 🔗 https://loom.ly/oSxOKDM

💊 Repurposing of losartan for the treatment of Osteogenesis Imperfecta (OI) One of REMEDi4ALL’s demonstrator projects is running a clinical trial investigating whether losartan could offer benefits for adolescents and adults with OI. 👉 Learn how to get involved here: https://loom.ly/uaJ_YgA

📣 Join experts from the Syreon Research Institute for an insightful webinar exploring Health Technology Assessment (HTA), Early HTA, and the role of patient preference evidence in the development and evaluation of repurposed medicines. 👉 Register here: https://loom.ly/P2DRFRA

🎬 The #iDR26 highlight reel is here! Hear from participants as they reflect on the importance of bringing the global drug repurposing community together to exchange ideas and address the challenges of delivering repurposed medicines to the patients who need them. 🔗 More: https://loom.ly/IGWmuZQ

📝 Read our recent interview with REMEDi4ALL iDR26 poster first author Nikoleta Efthymiopoulou We spoke with her about the research and her experience presenting a poster exploring the prevalence and impact of repurposing across modern drug development. 🔗 Read more: https://loom.ly/52o4MUM

📣 Join experts from the Syreon Research Institute for an insightful webinar exploring Health Technology Assessment (HTA), Early HTA, and the role of patient preference evidence in the development and evaluation of repurposed medicines. 👉 Register here: https://loom.ly/P2DRFRA

💊 Repurposing of losartan for the treatment of Osteogenesis Imperfecta (OI) One of REMEDi4ALL’s demonstrator projects is running a clinical trial investigating whether losartan could offer benefits for adolescents and adults with OI. 👉 Learn how to get involved here: https://loom.ly/uaJ_YgA

📣 Join experts from the Syreon Research Institute for an insightful webinar exploring Health Technology Assessment (HTA), Early HTA, and the role of patient preference evidence in the development and evaluation of repurposed medicines. 👉 Register here: https://loom.ly/P2DRFRA

📚New REMEDi4ALL publication in Nature Reviews Drug Discovery looks at lessons from the EU repurposing pilot under STAMP — and how collaboration can help bridge the gap between research and approval. Read more➡️: https://loom.ly/UqrNI8k #DrugRepurposing #EUHealth #STAMP

📣 Join experts from the Syreon Research Institute for an insightful webinar exploring Health Technology Assessment (HTA), Early HTA, and the role of patient preference evidence in the development and evaluation of repurposed medicines. 👉 Register here: https://loom.ly/P2DRFRA

🧪 New publication from REMEDi4ALL researchers! Aligning methods across labs improves the reliability of drug repurposing for pancreatic cancer. Researchers confirmed a consistent effect of combining two existing medicines and enhanced chemotherapy response. 📖 Read more: https://loom.ly/IATG6dg

Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Paris, 2-3 November 2026! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply before 10 June here: 🔗 https://loom.ly/GVUxULs#DrugRepurposing

🌐 Ahead of #iDR26, the REMEDi4ALL Funders Network met in Brussels, bringing together funders & policymakers. Discussions explored innovative #DrugRepurposing funding models, policy & regulatory conditions, and new tools supporting collaboration! 🔗Learn more: https://loom.ly/CxpCqYc#iDR26

The Medicines Reimagined Stakeholder Forum brings together the diverse voices driving innovation in drug repurposing. Whether you're an experienced stakeholder or new to the field, this community is for you! 👉 Join the forum today: https://remedi4all.org/stakeholder-forum

Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Paris, 2-3 November 2026! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗 https://loom.ly/GVUxULs#DrugRepurposing

Join the #REMEDi4ALL Drug Repurposing Bootcamp for Patient Representatives and lead the way in innovative treatment strategies! This training equips patient representatives with the essential knowledge and tools to drive innovation through drug repurposing Apply now! 🔗 https://loom.ly/GVUxULs#REMEDi4ALL

🔔 Last chance to apply for the REMEDi4ALL Hackathon! Applications close tomorrow (20 May, 23:59 CEST). Join multidisciplinary teams, get expert mentoring & work on impactful drug repurposing challenges. 📩 Apply now: https://loom.ly/lf9rypQ #DrugRepurposing #Hackathon

🎉That's a wrap on #iDR26! Over two packed days in Brussels, we brought together over 250 attendees from the global repurposing community for inspiring talks, panels, posters, and networking. Thanks again to our speakers and attendees! Read our highlights and takeaways here: https://loom.ly/IGWmuZQ

🎉 That's a wrap on the final day of #iDR26! Check out some of our highlights from today below! Thank you for joining us, for your active engagement, and for your valuable contributions. Special thanks to all speakers, moderators, panellists, sponsors, and partners who helped make #iDR26 possible.

💊 We are ready to kick off Day 2 of the International Drug Repurposing Conference #iDR26! We have an amazing agenda of Community and Industry track sessions and plenary sessions focusing on patient-centricity and the future of repurposing! 👉 Find the full agenda here: https://loom.ly/RA5Yss4

It's been an amazing first day at #iDR26, navigating the future of drug repurposing for patient benefit in Brussels! See you tomorrow for more track and plenary sessions! 👉 Check out some of the highlights from today's session below and find full agenda here: https://loom.ly/RA5Yss4

📮 💊From a repurposed post office in the heart of Brussels, the drug repurposing community came together to do what it does best: connect across disciplines, share ideas and turn collective expertise into action. Thank you to everyone who joined us. Bring on Day 2!

#iDR26 has officially begun at the historic Maison de la Poste in Brussels! It's amazing to be here together with the diverse repurposing community exploring the future of drug repurposing! 👉 Discover the full agenda here: https://loom.ly/RA5Yss4

🚨 Last chance to register for #iDR26 in Brussels next week! We're looking forward to welcoming you to Brussels for two inspiring days focused on shaping the future of drug repurposing. 🎟️ Don't have your ticket yet? A few places remain - register here: https://loom.ly/ToR-dtw

A new article in Nature Reviews Drug Discovery, inspired by discussions at previous International Drug Repurposing Conferences (iDR), explores how we can make the most of the potential of drug repurposing. 🔗 Read the article: https://bit.ly/4eyNFjq 🎟️ Register for iDR26: remedi4all.org/iDR26

📣 Introducing the final plenary session at #iDR26: The future of drug repurposing! At the closing session of #iDR26, we will explore potential challenges and our hope for the future of drug repurposing. 📅 12–13 May 2026, Brussels 🔗 Learn more and register here: https://loom.ly/9dw7qdk

⌛ Are you an early‑career researcher interested in drug repurposing? The REMEDi4ALL #Hackathon brings together multidisciplinary teams to learn from experts and explore hands-on how existing medicines can reach patients. ➡️Applications close soon – apply now: https://loom.ly/2V3NnfI

We're excited to welcome you to Brussels next week for #iDR26 - the 2026 International Drug Repurposing Conference! 🎟️ Final tickets are available: https://loom.ly/ToR-dtw Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: https://loom.ly/RA5Yss4

🔎 How can we shape a better drug repurposing policy landscape? New REMEDi4ALL work in Health Policy OPEN uses multi‑stakeholder input to prioritise barriers and inform actionable reforms. Join #iDR26 to learn more🎟️: https://loom.ly/gh97s9k REMEDi4ALL summary here➡️: https://loom.ly/IdIBEak

Plenary Session I at #iDR26! At the first session of iDR26, we'll dive into the innovative developments in the field of drug repurposing and meet the patient groups, funders, and regulators driving that change. 📅 12–13 May 2026, Brussels 🔗 Learn more and register here: https://loom.ly/9dw7qdk

📢The full programme for #iDR26 is now live! Join us on 12–13 May 2026 for iDR26 – Navigating the future, bringing the global drug repurposing community together for two days of discussion, collaboration & patient-focused insight. 🎟️ Explore the programme and register: https://loom.ly/RA5Yss4

🔬New REMEDi4ALL publication in Patterns! Researchers analysed 5000+ repurposed compounds to build an ML model predicting drug‑induced phospholipidosis helping reduce false positives in early drug screening. 📚Read the publication: https://loom.ly/dhGyf_M 🎟️More at #iDR26: https://loom.ly/9dw7qdk

⏳REMEDi4ALL #Hackathon: applications close next week! Join a unique, hands‑on experience where #EarlyCareerResearchers come together to tackle real‑world drug repurposing challenges and turn ideas into impact. 📅 Applications closing soon - don’t miss out➡️: https://loom.ly/2V3NnfI#Hackathon#EarlyCareerResearchers

🧭 Welcome to LifeArc, Bronze Sponsor of #iDR26! LifeArc is a not-for-profit medical research organisation transforming lives through pioneering research in rare diseases and drug‑resistant infections.s. 🔗 More on LifeArc: https://loom.ly/pzFCQ1o 🎟️ Register for #iDR26: https://loom.ly/9dw7qdk#iDR26

Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Paris, 2-3 November 2026! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗https://loom.ly/GVUxULs#DrugRepurposing

📣 #iDR26 keeps growing its speaker line-up! Join us to exchange insights, develop collaborations and explore how repurposing can accelerate development timelines and improve access to effective treatments worldwide. 📅 12–13 May 2026, Brussels 🔗 https://loom.ly/9dw7qdk

💊 Speakers at #iDR25, Daria Julkowska, Christophe Lahorte and Natasha Spottiswoode, reflect on the impact of REMEDi4ALL on the drug repurposing landscape. Join us in Brussels on 12-13 May and see what we have developed at #iDR26! 👉 Register now: www.remedi4all.org/iDR26

🚨REMEDi4ALL Hackathon 2026: applications open! Looking to strengthen your #DrugRepurposing skills? This immersive training event is designed for early-career researchers to learn by doing. 📅6–11 Sep 2026 |📍Montserrat, Barcelona 🎥Hear from 2025 participants and apply: https://loom.ly/2V3NnfI

Exploring #iDR26 Repurposing Community (II) 🤝 In this session, we’ll explore public–private partnerships as a powerful model within the repurposing ecosystem, and look into what it really takes to upskill people for more successful repurposing studies. 🔗 https://loom.ly/9dw7qdk

💭 What can the REMEDi4ALL #Hackathon 2026 offer you? A residential, hands-on training bringing together #EarlyCareerResearchers from across Europe to work on real-life #DrugRepurposing challenges. 🎬 Hear from REMEDi4ALL organisers & apply now 👉 https://loom.ly/2V3NnfI

⏳#iDR26 is almost here! One month to go until the drug repurposing community comes together to explore what’s next in patient‑centric medicines repurposing. This year’s conference will take place at Maison de la Poste, a reimagined industrial landmark. 👉 https://loom.ly/9dw7qdk

🌍 The work of REMEDi4ALL was recently featured in American Magazine Reader's Digest, including quotes from Donald Lo (REMEDi4ALL Scientific Lead). Interested in learning more about the future of drug repurposing? Join us at #iDR26 on 12-13 May in Brussels, Belgium! 🔗 https://loom.ly/9dw7qdk

What structural barriers are holding back drug repurposing funding? This REMEDi4ALL Funders Network white paper describes what is needed from a funders’ perspective to accelerate the repurposing path for the ultimate benefit of patients. 👉 Read more here: https://loom.ly/3TLAfvc

Explore the Patient Engagement Panel at #iDR26 This session focuses on the challenges faced by rare disease communities. Led by patient advocates and representatives, this panel unpacks the barriers that limit access and the steps communities are taking to overcome them. 🔗https://loom.ly/9dw7qdk#iDR26

Introducing the plenary session: Creating repurposing ecosystems. This #iDR26 session will highlight key innovations in the Spanish drug development network, from patient engagement and academic research support to regulatory and reimbursement programs and incentives. 👉 https://loom.ly/9dw7qdk#iDR26

📣 Applications now open: REMEDi4ALL Hackathon 2026 Join the REMEDi4ALL #Hackathon 2026 (6–11 Sept, Montserrat, Barcelona) for hands-on drug repurposing training for early-career researchers. 💬 Hear from 2025 participants & register today 👉 https://loom.ly/2V3NnfI#Hackathon #EarlyCareerResearchers

Discover the #iDR26 Lightning Talks Get ready for a fast‑paced session showcasing the innovation within the #REMEDi4ALL community. Six speakers from diverse backgrounds will take the stage to share stories designed to inform, inspire, and spark new collaborations. 🔗 https://loom.ly/9dw7qdk

👥 This week REMEDi4ALL hosted its 3rd multi‑stakeholder meeting in London, bringing together clinicians, patient organisations, industry, HTA & regulatory experts to connect around drug repurposing for ultra‑rare epilepsies. 🔎 Learn more about REMEDi4ALL ➡️ https://loom.ly/Ne32Kbk